z-logo
open-access-imgOpen Access
Klotho inhibits the capacity of cell migration and invasion in cervical cancer
Author(s) -
Boogi Chang,
JinSun Kim,
Dongjun Jeong,
Yujun Jeong,
Seob Jeon,
Samil Jung,
Young Yang,
Keun Il Kim,
JongSeok Lim,
Changjin Kim,
MyeongSok Lee
Publication year - 2012
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2012.1865
Subject(s) - wnt signaling pathway , cancer research , epithelial–mesenchymal transition , klotho , oncogene , downregulation and upregulation , ectopic expression , cell cycle , biology , catenin , cyclin d1 , cancer , microbiology and biotechnology , signal transduction , cell culture , endocrinology , kidney , gene , biochemistry , genetics
Aberrant activation of the Wnt/β-catenin signaling pathway is common inhuman cervical cancers. However, the mechanisms of Wnt activation in cervicalcancer remain largely unknown. In the present study, we demonstrate that Klotho,a Wnt antagonist, is downregulated in invasive human cervical tumors and in acell line we analyzed. Our data demonstrated that in vivo Klotho expression wasnot observed in invasive cervical carcinoma. In vitro restoration of Klotho expressionin SiHa cells resulted in a decreased cell motility and invasiveness through upregulationof E-cadherin, downregulation of N-cadherin and reduced expression of MMP7 and-9. Ectopic expression of Klotho also reduced the expression of the epithelial-to-mesenchymaltransition (EMT) transcription factors Slug and Twist. Furthermore, Klotho causesa significant inhibition of the Wnt/β-catenin pathway in cervical cancer cells,as supported by the expression of Wnt/β-catenin transcriptional target genes suchas c-Myc and cyclin D1. Consequently, our findings demonstrate for the first timethat Klotho regulates tumor invasion through the EMT process and provide novelmechanistic insights into the role of Klotho in cervical cancer progression andcontribute to treatment for metastatic cervical cancer patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom